| Current Price | $65.73 | Mkt Cap | $83.2B |
|---|---|---|---|
| Open | $65.10 | P/E Ratio | 31.11 |
| Prev. Close | $64.88 | Div. (Yield) | $2.46 (3.7%) |
| Daily Range | $64.51 - $65.80 | Volume | 5,361,430 |
| 52-Wk Range | $60.89 - $70.50 | Avg. Daily Vol. | 6,060,142 |
A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.
| Current Price | $65.73 | Mkt Cap | $83.2B |
|---|---|---|---|
| Open | $65.10 | P/E Ratio | 31.11 |
| Prev. Close | $64.88 | Div. (Yield) | $2.46 (3.7%) |
| Daily Range | $64.51 - $65.80 | Volume | 5,361,430 |
| 52-Wk Range | $60.89 - $70.50 | Avg. Daily Vol. | 6,060,142 |
The best Bull and Bear pitches based on recency and number of recommendations.
This company has proved that it can cure diseases. It has over $30B in cash. Good mgmt. Good yield. As of today at has a P/E of 7. If this company was not here tomorrow, people would notice.
Patent problems and trouble with cancer drug trials.
Read the most recent pitches from players about GILD.
Recs
tester007
(< 20)
Submitted: 4/8/2019 8:29:11 AM :
Start Price:
$65.95
NASDAQ:GILD Score:
-8.06
just a year or so
Recs
elv1659
(< 20)
Submitted: 4/2/2019 3:25:10 PM :
Start Price:
$65.18
NASDAQ:GILD Score:
-7.64
This company is the leading cure hep c and will do well. Many people get hep c from needles and use of drugs and the demand for a cure is extreme.
Recs
TMFEBCapital
(85.15)
Submitted: 11/20/2018 11:14:15 AM :
Start Price:
$66.20
NASDAQ:GILD Score:
-17.53
NASH data and filgotinib data in 2019 could finally mark the long-awaited turning point for this company. It's HCV drag should wane next year, allowing HIV sales growth and potentially, new drug approvals, to return it to top line growth in 2020.
Find the members with the highest scoring picks in GILD.
BrianMotleyFool (64.82) Score: +536.73
The Score Leader is the player with the highest score across all their picks in GILD.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| UrineLuck73 | < 20 | 1/29/2007 |
|
NS | $13.94 | +371.45% | +131.66% | +239.78 | 0 Comment | |
| WilliamCrook2003 | 71.00 |
|
|
5Y | $13.94 | +371.45% | +131.66% | +239.78 | 1 Comment | |
| JSergeant | 64.75 | 7/3/2006 |
|
3Y | $13.20 | +397.83% | +159.45% | +238.38 | 0 Comment | |
| predragj | 47.30 | 1/30/2007 |
|
NS | $14.12 | +365.48% | +131.40% | +234.08 | 0 Comment | |
| mxdfool | < 20 | 12/15/2006 |
|
5Y | $14.19 | +363.35% | +130.60% | +232.75 | 0 Comment | |
| betsypurcell | < 20 | 1/24/2007 |
|
NS | $14.21 | +362.71% | +130.40% | +232.31 | 0 Comment | |
| opveiby | 77.96 | 1/25/2007 |
|
5Y | $14.31 | +359.24% | +129.00% | +230.24 | 0 Comment | |
| Redskins2k9 | < 20 | 1/25/2007 |
|
5Y | $14.31 | +359.24% | +129.00% | +230.24 | 0 Comment | |
| rmarinchek | < 20 | 1/25/2007 |
|
3W | $14.31 | +359.24% | +129.00% | +230.24 | 0 Comment | |
| jer8899 | 68.65 | 1/23/2007 |
|
NS | $14.28 | +360.25% | +130.43% | +229.82 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
